Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer. In ...

A cancer diagnosis is serious, but immediately starting treatment sometimes isn't the best course of action. ljubaphoto/E+ via Getty Images Although about 1 in 8 men in the U.S. will be diagnosed with ...

Half of men with low-risk prostate cancer remained free from progression or treatment 10 years after diagnosis when followed in a protocol-directed active surveillance program. At 10 years, 43% of ...

Seventeen years ago, Philip Segal, a retired accountant from suburban Toronto, Canada, was diagnosed with prostate cancer in a private clinic. After rejecting brachytherapy recommended by an ...

Come December, as I observe my "pros-mitzvah" -- 13 years on active surveillance (AS) for very low-risk prostate cancer -- I feel I'm at a tipping point. Should I stay the course and keep monitoring ...

Prostate cancer is the most common solid malignancy among men in the United States. According to the American Cancer Society, an estimated 313,780 men nationwide will be diagnosed with the disease in ...

Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, ...

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said. Active surveillance has been shown to be an effective management strategy for ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...